Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates

Go back to Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates

Windtree Therapeutics, Inc. (WINT) Reports Q4 Loss of $0.77

March 31, 2017 7:35 AM EDT

Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q4 EPS of ($0.77), versus ($1.26) reported last year.

For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.

... More